{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:13:10Z","timestamp":1791184390375,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1038\/sj.ijo.0801732","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T16:33:08Z","timestamp":1032453188000},"page":"1454-1458","source":"Crossref","is-referenced-by-count":20,"title":["Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release"],"prefix":"10.1038","volume":"25","author":[{"given":"IC","family":"Kilpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Traut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DJ","family":"Heal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,10,23]]},"reference":[{"key":"BF0801732_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0146-2806(99)90013-0","volume":"24","author":"HM Connolly","year":"1999","unstructured":"Connolly HM, McGoon MD . Obesity drugs and the heart Curr Probl Cardiol 1999 24: 751\u2013792.","journal-title":"Curr Probl Cardiol"},{"key":"BF0801732_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","volume":"283","author":"JM Gardin","year":"2000","unstructured":"Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL . Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine JAMA 2000 283: 1703\u20131709.","journal-title":"JAMA"},{"key":"BF0801732_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199608293350901","volume":"335","author":"L Abenhaim","year":"1996","unstructured":"Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simmoneau G, B\u00e9gaud B . Appetite-suppressant drugs and the risk of primary pulmonary hypertension New Engl J Med 1996 335: 609\u2013616.","journal-title":"New Engl J Med"},{"key":"BF0801732_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.CIR.99.1.156","volume":"99","author":"AP Fishman","year":"1999","unstructured":"Fishman AP . Aminorex to Fen\/Phen. An epidemic foretold Circulation 1999 99: 156\u2013161.","journal-title":"Circulation"},{"key":"BF0801732_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herv\u00e9","year":"1995","unstructured":"Herv\u00e9 P, Launay J-M, Scrobohaci M-L, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L . Increased plasma serotonin in primary pulmonary hypertension Am J Med 1995 99: 249\u2013254.","journal-title":"Am J Med"},{"key":"BF0801732_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","volume":"92","author":"PA Robiolio","year":"1995","unstructured":"Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM . Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography Circulation 1995 92: 790\u2013795.","journal-title":"Circulation"},{"key":"BF0801732_CR7","first-page":"75","volume":"57","author":"LW Fitzgerald","year":"2000","unstructured":"Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun J-H, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW . Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine Mol Pharmac 2000 57: 75\u201381.","journal-title":"Mol Pharmac"},{"key":"BF0801732_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#","volume":"36","author":"MH Baumann","year":"2000","unstructured":"Baumann MH, Ayestas MA, Dersch CM, Brockington A, Rice KC, Rothman RB . Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications Synapse 2000 36: 102\u2013113.","journal-title":"Synapse"},{"key":"BF0801732_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W","volume":"38","author":"HL Rowley","year":"2000","unstructured":"Rowley HL, Butler SA, Prow MR, Dykes SG, Aspley S, Kilpatrick IC, Heal DJ . A comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely-moving rats Synapse 2000 38: 167\u2013176.","journal-title":"Synapse"},{"key":"BF0801732_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S0006-2952(00)00306-3","volume":"59","author":"IH Ulus","year":"2000","unstructured":"Ulus IH, Maher TJ and Wurtman RJ . Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors Biochem Pharmac 2000 59: 1611\u20131621.","journal-title":"Biochem Pharmac"},{"key":"BF0801732_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1098-2396(199905)32:2<141::AID-SYN8>3.0.CO;2-R","volume":"32","author":"RB Rothman","year":"1999","unstructured":"Rothman RB . Is phentermine an inhibitor of monoamine oxidase? A critical appraisal. Synapse 1999 32: 141\u2013145.","journal-title":"Synapse"},{"key":"BF0801732_CR12","first-page":"66P","volume":"128","author":"IC Kilpatrick","year":"1999","unstructured":"Kilpatrick IC, Traut M, Heal DJ . Monoamine oxidase inhibition determined in rat brain is unlikely to account for cardiovascular risks associated with fenfluramine and phentermine Br J Pharmac 1999 128: 66P.","journal-title":"Br J Pharmac"},{"key":"BF0801732_CR13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/0006-2952(63)90215-6","volume":"12","author":"RJ Wurtman","year":"1963","unstructured":"Wurtman RJ, Axelrod J . A sensitive and specific assay for the estimation of monoamine oxidase Biochem Pharmac 1963 12: 1439\u20131441.","journal-title":"Biochem Pharmac"},{"key":"BF0801732_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0028-3908(75)90109-4","volume":"14","author":"JA Fuentes","year":"1975","unstructured":"Fuentes JA, Neff NH . Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes Neuropharmacology 1975 14: 819\u2013825.","journal-title":"Neuropharmacology"},{"issue":"Suppl","key":"BF0801732_CR15","first-page":"321","volume":"41","author":"S Henriot","year":"1994","unstructured":"Henriot S, Kuhn C, Kettler R, Da Prada M . Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings J Neural Transm 1994 41 (Suppl): 321\u2013325.","journal-title":"J Neural Transm"},{"key":"BF0801732_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/npp.1994.26","volume":"10","author":"ETK Leonardi","year":"1994","unstructured":"Leonardi ETK, Azmitia EC . MDMA (Ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac) Neuropsychopharmacology 1994 10: 231\u2013238.","journal-title":"Neuropsychopharmacology"},{"key":"BF0801732_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00168701","volume":"354","author":"A Holt","year":"1996","unstructured":"Holt A, Baker GB . Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine Naunyn-Schmiedeberg's Arch Pharmac 1996 354: 17\u201324.","journal-title":"Naunyn-Schmiedeberg's Arch Pharmac"},{"key":"BF0801732_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0014-2999(97)01233-8","volume":"337","author":"J Mukherjee","year":"1997","unstructured":"Mukherjee J, Yang Z-Y . Evaluation of monoamine oxidase B inhibition by fluoxetine (Prozac): an in vitro and in vivo study Eur J Pharmac 1997 337: 111\u2013114.","journal-title":"Eur J Pharmac"},{"key":"BF0801732_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","volume":"12","author":"WR Buckett","year":"1988","unstructured":"Buckett WR, Thomas PC, Luscombe GP . The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation Prog Neuro-Psychopharmac Biol Psychiatr 1988 12: 575\u2013584.","journal-title":"Prog Neuro-Psychopharmac Biol Psychiatr"},{"key":"BF0801732_CR20","first-page":"63","volume-title":"Amphetamines and related compounds.","author":"I Moller Nielsen","year":"1970","unstructured":"Moller Nielsen I, Dubnick B . Pharmacology of chlorphentermine. In: Costa E, Garattini S (eds). Amphetamines and related compounds. Raven Press: New York 1970 63\u201373."},{"key":"BF0801732_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.2042-7158.1973.tb09162.x","volume":"25","author":"K-U Seiler","year":"1973","unstructured":"Seiler K-U, Wasserman O . MAO-inhibitory properties of anorectic drugs J Pharm Pharmac 1973 25: 576\u2013578.","journal-title":"J Pharm Pharmac"},{"key":"BF0801732_CR22","doi-asserted-by":"publisher","first-page":"(Suppl): S6","DOI":"10.1007\/BF02246225","volume":"106","author":"W Haefely","year":"1992","unstructured":"Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR, Richards JG, Scherschlicht R, Da Prada M . Biochemistry and pharmacology of moclobemide, a prototype RIMA Psychopharmacology 1992 106: (Suppl): S6\u201314.","journal-title":"Psychopharmacology"},{"key":"BF0801732_CR23","first-page":"276","volume":"170","author":"J Duhault","year":"1967","unstructured":"Duhault J, Verdavainne C . Modification du taux de s\u00e9rotonine c\u00e9r\u00e9brale chez le rat par les triflurom\u00e9thyl-ph\u00e9nyl-2 \u00e9thyl aminopropane (fenfluramine 768 S) Arch Int Pharmacodyn 1967 170: 276\u2013286.","journal-title":"Arch Int Pharmacodyn"},{"key":"BF0801732_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0024-3205(72)90166-X","volume":"11","author":"D Morgan","year":"1972","unstructured":"Morgan D, L\u00f6fstrandh S, Costa E . Amphetamine analogues and brain amines Life Sci 1972 11: 83\u201396.","journal-title":"Life Sci"},{"key":"BF0801732_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1476-5381.1975.tb07395.x","volume":"53","author":"W Buczko","year":"1975","unstructured":"Buczko W, De Gaetano G, Garattini S . Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets Br J Pharmac 1975 53: 563\u2013568.","journal-title":"Br J Pharmac"},{"key":"BF0801732_CR26","first-page":"155P","volume":"129","author":"Lane","year":"2000","unstructured":"Lane, EL, Prow, MR, Aspley, S, Kilpatrick IC, Heal DJ . d-Fenfluramine releases 5HT from whole blood of rats as measured by in vitro microdialysis Br J Pharmac 2000 129: 155P.","journal-title":"Br J Pharmac"},{"key":"BF0801732_CR27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0024-3205(94)00663-6","volume":"55","author":"P Celada","year":"1994","unstructured":"Celada P, Martin F, Artigas F . Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue Life Sci 1994 55: 1237\u20131243.","journal-title":"Life Sci"},{"key":"BF0801732_CR28","first-page":"1773","volume":"337","author":"B Redmon","year":"1997","unstructured":"Redmon B, Raatz S, Bantle JP . Valvular heart disease associated with fenfluramine-phentermine New Engl J Med 1997 337: 1773\u20131774.","journal-title":"New Engl J Med"},{"key":"BF0801732_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0002-9149(99)00896-6","volume":"85","author":"RB Rothman","year":"2000","unstructured":"Rothman RB, Redmon JB, Raatz SK, Kwong CA, Swanson JE, Bantle JP . Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin Am J Cardiol 2000 85: 913\u2013915.","journal-title":"Am J Cardiol"},{"key":"BF0801732_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","volume":"125","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Cheetham SC, Prow MR, Martin KF, Buckett WR . A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents Br J Pharmacol 1998 125: 301\u2013308.","journal-title":"Br J Pharmacol"},{"key":"BF0801732_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0028-3908(93)90181-2","volume":"32","author":"SC Cheetham","year":"1993","unstructured":"Cheetham SC, Viggers JA, Slater NA, Heal DJ, Buckett WR . [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments Neuropharmacology 1993 32: 737\u2013743.","journal-title":"Neuropharmacology"},{"key":"BF0801732_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","volume":"100","author":"RB Rothman","year":"1999","unstructured":"Rothman RB, Ayestas MA, Dersch CM, Baumann MH . Aminorex, fenfluramine and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension Circulation 1999 100: 869\u2013875.","journal-title":"Circulation"},{"key":"BF0801732_CR33","first-page":"143P","volume":"12","author":"B Lancashire","year":"1998","unstructured":"Lancashire B, Viggers J, Prow MR, Aspley S, Martin KF, Cheetham SC, Heal DJ . Monamine release and uptake inhibition profiles of antiobesity agents J Psychopharmacol 1998 12 (Suppl A): 143P.","journal-title":"J Psychopharmacol"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0801732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801732","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0801732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:19:29Z","timestamp":1684221569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0801732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["BF0801732"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0801732","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}